Skip to main content
Erschienen in: Breast Cancer Research 1/2008

01.02.2008 | Review

Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence

verfasst von: Lisa J Martin, Norman F Boyd

Erschienen in: Breast Cancer Research | Sonderheft 1/2008

Einloggen, um Zugang zu erhalten

Abstract

There is now extensive evidence that mammographic density is an independent risk factor for breast cancer that is associated with large relative and attributable risks for the disease. The epidemiology of mammographic density, including the influences of age, parity and menopause, is consistent with it being a marker of susceptibility to breast cancer, in a manner similar to the concept of 'breast tissue age' described by the Pike model. Mammographic density reflects variations in the tissue composition of the breast. It is associated positively with collagen and epithelial and nonepithelial cells, and negatively with fat. Mammographic density is influenced by some hormones and growth factors as well as by several hormonal interventions. It is also associated with urinary levels of a mutagen. Twin studies have shown that most of the variation in mammographic density is accounted for by genetic factors. The hypothesis that we have developed from these observations postulates that the combined effects of cell proliferation (mitogenesis) and genetic damage to proliferating cells by mutagens (mutagenesis) may underlie the increased risk for breast cancer associated with extensive mammographic density. There is clearly a need for improved understanding of the specific factors that are involved in these processes and of the role played by the several breast tissue components that contribute to density. In particular, identification of the genes that are responsible for most of the variance in percentage density (and of their biological functions) is likely to provide insights into the biology of the breast, and may identify potential targets for preventative strategies in breast cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wolfe JN: Breast patterns as an index of risk for developing breast cancer. A J Roentgenol. 1976, 126: 1130-1137.CrossRef Wolfe JN: Breast patterns as an index of risk for developing breast cancer. A J Roentgenol. 1976, 126: 1130-1137.CrossRef
2.
Zurück zum Zitat Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976, 37: 2486-2492. 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8.PubMedCrossRef Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976, 37: 2486-2492. 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8.PubMedCrossRef
3.
Zurück zum Zitat McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.PubMedCrossRef McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1159-1169. 10.1158/1055-9965.EPI-06-0034.PubMedCrossRef
4.
Zurück zum Zitat Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356: 227-236. 10.1056/NEJMoa062790.PubMedCrossRef Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356: 227-236. 10.1056/NEJMoa062790.PubMedCrossRef
6.
Zurück zum Zitat Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983, 303: 767-770. 10.1038/303767a0.PubMedCrossRef Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983, 303: 767-770. 10.1038/303767a0.PubMedCrossRef
7.
Zurück zum Zitat Grove JS, Goodman MJ, Gilbert F, Mi MP: Factors associated with mammographic pattern. Br J Radiol. 1985, 58: 21-25.PubMedCrossRef Grove JS, Goodman MJ, Gilbert F, Mi MP: Factors associated with mammographic pattern. Br J Radiol. 1985, 58: 21-25.PubMedCrossRef
8.
Zurück zum Zitat Vachon CM, Kuni CC, Anderson K: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.PubMedCrossRef Vachon CM, Kuni CC, Anderson K: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662. 10.1023/A:1008926607428.PubMedCrossRef
9.
Zurück zum Zitat Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed
10.
Zurück zum Zitat Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2086-2092. 10.1158/1055-9965.EPI-06-0345.PubMedCrossRef Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S: Body size, mammographic density and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2086-2092. 10.1158/1055-9965.EPI-06-0345.PubMedCrossRef
11.
Zurück zum Zitat Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N: The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 343-349. 10.1158/1055-9965.EPI-04-0490.PubMedCrossRef Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N: The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 343-349. 10.1158/1055-9965.EPI-04-0490.PubMedCrossRef
12.
Zurück zum Zitat Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M: A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1048-1053.PubMed Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M: A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1048-1053.PubMed
13.
Zurück zum Zitat Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, Milanese T, Carston MJ, Sellers TA: Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007, 16: 921-928. 10.1158/1055-9965.EPI-06-1047.PubMedCrossRef Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, Milanese T, Carston MJ, Sellers TA: Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007, 16: 921-928. 10.1158/1055-9965.EPI-06-1047.PubMedCrossRef
14.
Zurück zum Zitat Maskarinec G, Pagano I, Lurie G, Kolonel LN: A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2006, 15: 732-739. 10.1158/1055-9965.EPI-05-0798.PubMedCrossRef Maskarinec G, Pagano I, Lurie G, Kolonel LN: A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2006, 15: 732-739. 10.1158/1055-9965.EPI-05-0798.PubMedCrossRef
15.
Zurück zum Zitat Hart BL, Steinbock RT, Mettler FA, Pathak DR, Bartow SA: Age and race related changes in mammographic parenchymal patterns. Cancer. 1989, 63: 2537-2539. 10.1002/1097-0142(19890615)63:12<2537::AID-CNCR2820631230>3.0.CO;2-0.PubMedCrossRef Hart BL, Steinbock RT, Mettler FA, Pathak DR, Bartow SA: Age and race related changes in mammographic parenchymal patterns. Cancer. 1989, 63: 2537-2539. 10.1002/1097-0142(19890615)63:12<2537::AID-CNCR2820631230>3.0.CO;2-0.PubMedCrossRef
16.
Zurück zum Zitat Bartow SA, Mettler FA, Black WC: Correlations between radiographic patterns and morphology of the female breast. Rad Patterns Morph. 1997, 13: 263-275. Bartow SA, Mettler FA, Black WC: Correlations between radiographic patterns and morphology of the female breast. Rad Patterns Morph. 1997, 13: 263-275.
17.
Zurück zum Zitat Kelsey JL, Gammon MD, John ES: Reproductive factors and breast cancer. Epidemiol Rev. 1993, 15: 36-47.PubMedCrossRef Kelsey JL, Gammon MD, John ES: Reproductive factors and breast cancer. Epidemiol Rev. 1993, 15: 36-47.PubMedCrossRef
18.
Zurück zum Zitat Boyd NF, Jensen H, Cooke G, Lee Han HW: Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst. 1992, 84: 1170-1179. 10.1093/jnci/84.15.1170.PubMedCrossRef Boyd NF, Jensen H, Cooke G, Lee Han HW: Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst. 1992, 84: 1170-1179. 10.1093/jnci/84.15.1170.PubMedCrossRef
19.
Zurück zum Zitat Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985, 312: 146-151.PubMedCrossRef Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985, 312: 146-151.PubMedCrossRef
20.
Zurück zum Zitat Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al: Benign breast disease and the risk of breast cancer. N Engl J Med. 2005, 353: 229-237. 10.1056/NEJMoa044383.PubMedCrossRef Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al: Benign breast disease and the risk of breast cancer. N Engl J Med. 2005, 353: 229-237. 10.1056/NEJMoa044383.PubMedCrossRef
21.
Zurück zum Zitat Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, et al: Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006, 98: 1600-1607.PubMedCrossRef Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, et al: Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006, 98: 1600-1607.PubMedCrossRef
22.
Zurück zum Zitat Zangani D, Darcy KM, Masso-Welch PA, Bellamy ES, Desole MS, Ip MM: Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation. Differentiation. 1999, 64: 91-101. 10.1046/j.1432-0436.1999.6420091.x.PubMedCrossRef Zangani D, Darcy KM, Masso-Welch PA, Bellamy ES, Desole MS, Ip MM: Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation. Differentiation. 1999, 64: 91-101. 10.1046/j.1432-0436.1999.6420091.x.PubMedCrossRef
23.
Zurück zum Zitat Provenzano PO, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ: Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006, 4: 38-10.1186/1741-7015-4-38.PubMedPubMedCentralCrossRef Provenzano PO, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ: Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006, 4: 38-10.1186/1741-7015-4-38.PubMedPubMedCentralCrossRef
24.
25.
26.
Zurück zum Zitat Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ: Mammographic densities and circulating hormones: A cross-sectional study in premenopausal women. Breast. 2006, 15: 20-28. 10.1016/j.breast.2005.04.014.PubMedCrossRef Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ: Mammographic densities and circulating hormones: A cross-sectional study in premenopausal women. Breast. 2006, 15: 20-28. 10.1016/j.breast.2005.04.014.PubMedCrossRef
27.
Zurück zum Zitat Tamimi RM, Hankinson SE, Colditz GA, Byrne C: Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2641-2647. 10.1158/1055-9965.EPI-05-0558.PubMedCrossRef Tamimi RM, Hankinson SE, Colditz GA, Byrne C: Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2641-2647. 10.1158/1055-9965.EPI-05-0558.PubMedCrossRef
28.
Zurück zum Zitat Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A: Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1411-1417. 10.1158/1055-9965.EPI-04-0920.PubMedCrossRef Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A: Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1411-1417. 10.1158/1055-9965.EPI-04-0920.PubMedCrossRef
29.
Zurück zum Zitat Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, Healey CS, Dunning A, Doody D, Ponder B, et al: Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers & Prev. 2006, 15: 1502-1508. 10.1158/1055-9965.EPI-05-0828.CrossRef Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E, Healey CS, Dunning A, Doody D, Ponder B, et al: Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers & Prev. 2006, 15: 1502-1508. 10.1158/1055-9965.EPI-05-0828.CrossRef
30.
Zurück zum Zitat Verheus M, Peeters PHM, van Noord PAH, van der Schouw YT, Grobbee DE, van Gils CH: No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res. 2007, 9: R53-10.1186/bcr1758.PubMedPubMedCentralCrossRef Verheus M, Peeters PHM, van Noord PAH, van der Schouw YT, Grobbee DE, van Gils CH: No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res. 2007, 9: R53-10.1186/bcr1758.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S: The association of breast mitogens with mammographic densities. Br J Cancer. 2002, 87: 876-882. 10.1038/sj.bjc.6600537.PubMedPubMedCentralCrossRef Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S: The association of breast mitogens with mammographic densities. Br J Cancer. 2002, 87: 876-882. 10.1038/sj.bjc.6600537.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT: Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer. 2007, 121: 2506-2511. 10.1002/ijc.22971.PubMedCrossRef Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT: Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer. 2007, 121: 2506-2511. 10.1002/ijc.22971.PubMedCrossRef
33.
Zurück zum Zitat Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA: The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol. 2005, 162: 826-834. 10.1093/aje/kwi286.PubMedCrossRef Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA: The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol. 2005, 162: 826-834. 10.1093/aje/kwi286.PubMedCrossRef
34.
Zurück zum Zitat Greendale GA, Huang MH, Ursin G, Ingles S, Stanczyk F, Crandall C, Laughlin GA, Barrett-Connor E, Karlamangla A: Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat. 2007, 105: 337-346. 10.1007/s10549-006-9454-y.PubMedCrossRef Greendale GA, Huang MH, Ursin G, Ingles S, Stanczyk F, Crandall C, Laughlin GA, Barrett-Connor E, Karlamangla A: Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat. 2007, 105: 337-346. 10.1007/s10549-006-9454-y.PubMedCrossRef
35.
Zurück zum Zitat Byrne C, Colditz GA, Pollak M, Willet WC, Speizer FE, Hankinson SE: Plasma insulin-like growth factor-I, insulin-like growth factor binding protein-3 and mammographic density. Cancer Res. 2000, 60: 3744-3748.PubMed Byrne C, Colditz GA, Pollak M, Willet WC, Speizer FE, Hankinson SE: Plasma insulin-like growth factor-I, insulin-like growth factor binding protein-3 and mammographic density. Cancer Res. 2000, 60: 3744-3748.PubMed
36.
Zurück zum Zitat Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C, Brisson J: Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1065-1073. 10.1158/1055-9965.EPI-04-0706.PubMedCrossRef Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C, Brisson J: Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1065-1073. 10.1158/1055-9965.EPI-04-0706.PubMedCrossRef
37.
Zurück zum Zitat Maskarinec G, Williams AE, Kaaks R: A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer. 2003, 107: 991-996. 10.1002/ijc.11505.PubMedCrossRef Maskarinec G, Williams AE, Kaaks R: A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer. 2003, 107: 991-996. 10.1002/ijc.11505.PubMedCrossRef
38.
Zurück zum Zitat dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejía G, Fletcher O, Allen DS, Allen NE, Key TJ, Fentiman IS, Holly JM, et al: The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2006, 15: 449-455. 10.1158/1055-9965.EPI-05-0555.PubMedCrossRef dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejía G, Fletcher O, Allen DS, Allen NE, Key TJ, Fentiman IS, Holly JM, et al: The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2006, 15: 449-455. 10.1158/1055-9965.EPI-05-0555.PubMedCrossRef
39.
Zurück zum Zitat Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT: Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev. 2007, 16: 57-62. 10.1158/1055-9965.EPI-06-0788.PubMedCrossRef Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT: Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev. 2007, 16: 57-62. 10.1158/1055-9965.EPI-06-0788.PubMedCrossRef
40.
Zurück zum Zitat Verheus M, Peeters PHM, Kaaks R, van Noord PAH, Grobbee DE, van Gils CH: Premenopausal insuln-like growth factor-1 serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev. 2007, 16: 451-457. 10.1158/1055-9965.EPI-06-0642.PubMedCrossRef Verheus M, Peeters PHM, Kaaks R, van Noord PAH, Grobbee DE, van Gils CH: Premenopausal insuln-like growth factor-1 serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev. 2007, 16: 451-457. 10.1158/1055-9965.EPI-06-0642.PubMedCrossRef
41.
Zurück zum Zitat Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF: Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev. 2001, 10: 243-248.PubMed Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF: Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev. 2001, 10: 243-248.PubMed
42.
Zurück zum Zitat Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH: Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003, 5: R129-R135. 10.1186/bcr622.PubMedPubMedCentralCrossRef Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH: Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003, 5: R129-R135. 10.1186/bcr622.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, et al: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. JAMA. 2003, 289: 3243-3253. 10.1001/jama.289.24.3243.PubMedCrossRef Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, et al: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. JAMA. 2003, 289: 3243-3253. 10.1001/jama.289.24.3243.PubMedCrossRef
44.
Zurück zum Zitat Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003, 95: 30-37.PubMedCrossRef Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003, 95: 30-37.PubMedCrossRef
45.
Zurück zum Zitat Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B: Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol. 1999, 181: 348-352. 10.1016/S0002-9378(99)70560-0.PubMedCrossRef Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B: Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol. 1999, 181: 348-352. 10.1016/S0002-9378(99)70560-0.PubMedCrossRef
46.
Zurück zum Zitat Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176. 10.1001/jama.285.2.171.PubMedCrossRef Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176. 10.1001/jama.285.2.171.PubMedCrossRef
47.
Zurück zum Zitat Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004, 96: 621-628.PubMedCrossRef Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004, 96: 621-628.PubMedCrossRef
48.
Zurück zum Zitat Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436. 10.1093/jnci/86.6.431.PubMedCrossRef Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436. 10.1093/jnci/86.6.431.PubMedCrossRef
49.
Zurück zum Zitat Endogenous Hormones and Breast Cancer Collaborative Group, Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002, 94: 606-616.CrossRef Endogenous Hormones and Breast Cancer Collaborative Group, Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002, 94: 606-616.CrossRef
50.
Zurück zum Zitat Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006, 98: 1406-1415.PubMedCrossRef Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006, 98: 1406-1415.PubMedCrossRef
51.
Zurück zum Zitat Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007, 99: 1178-1187. 10.1093/jnci/djm062.PubMedCrossRef Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007, 99: 1178-1187. 10.1093/jnci/djm062.PubMedCrossRef
52.
Zurück zum Zitat Riza E, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A: Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2001, 10: 627-634.PubMed Riza E, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A: Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2001, 10: 627-634.PubMed
53.
Zurück zum Zitat Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S: Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2137-2142. 10.1158/1055-9965.EPI-04-0934.PubMedCrossRef Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S: Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2137-2142. 10.1158/1055-9965.EPI-04-0934.PubMedCrossRef
54.
Zurück zum Zitat Liehr JG: Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ Health Perspect. 1997, 105 (suppl 3): 565-569. 10.2307/3433371.PubMedPubMedCentralCrossRef Liehr JG: Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ Health Perspect. 1997, 105 (suppl 3): 565-569. 10.2307/3433371.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D: Estrogens as endogenous genotoxic agents – DNA adducts and mutations. J Natl Cancer Inst Monogr. 2000, 27: 75-93.CrossRef Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D: Estrogens as endogenous genotoxic agents – DNA adducts and mutations. J Natl Cancer Inst Monogr. 2000, 27: 75-93.CrossRef
56.
Zurück zum Zitat Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet. 1998, 351: 1393-1396. 10.1016/S0140-6736(97)10384-1.PubMedCrossRef Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet. 1998, 351: 1393-1396. 10.1016/S0140-6736(97)10384-1.PubMedCrossRef
57.
Zurück zum Zitat Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B, Speizer FE: Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1999, 91: 629-634. 10.1093/jnci/91.7.629.PubMedCrossRef Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B, Speizer FE: Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1999, 91: 629-634. 10.1093/jnci/91.7.629.PubMedCrossRef
58.
Zurück zum Zitat Pollak MN, Schernhammer ES, Hankinson SE: Insulin-like growth factors and neoplasia. Nature Reviews. 2004, 4: 505-518. 10.1038/nrc1387.PubMed Pollak MN, Schernhammer ES, Hankinson SE: Insulin-like growth factors and neoplasia. Nature Reviews. 2004, 4: 505-518. 10.1038/nrc1387.PubMed
59.
Zurück zum Zitat Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA: Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med. 1997, 3: 1141-1144. 10.1038/nm1097-1141.PubMedCrossRef Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA: Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med. 1997, 3: 1141-1144. 10.1038/nm1097-1141.PubMedCrossRef
60.
Zurück zum Zitat Tworoger SS, Eliassen AH, Sluss P, Hankinson SE: A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol. 2007, 25: 1482-1488. 10.1200/JCO.2006.07.6356.PubMedCrossRef Tworoger SS, Eliassen AH, Sluss P, Hankinson SE: A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol. 2007, 25: 1482-1488. 10.1200/JCO.2006.07.6356.PubMedCrossRef
61.
62.
Zurück zum Zitat Holmes MD, Pollak MN, Hankinson SE: Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 2002, 11: 862-867.PubMed Holmes MD, Pollak MN, Hankinson SE: Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 2002, 11: 862-867.PubMed
63.
Zurück zum Zitat Eliassen AH, Tworoger SS, Hankinson SE: Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer. 2007, 120: 1536-1541. 10.1002/ijc.22482.PubMedCrossRef Eliassen AH, Tworoger SS, Hankinson SE: Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer. 2007, 120: 1536-1541. 10.1002/ijc.22482.PubMedCrossRef
64.
Zurück zum Zitat Valko M, Izakovic M, Mazur M, Rhodes CJ, Talser J: Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004, 266: 37-56. 10.1023/B:MCBI.0000049134.69131.89.PubMedCrossRef Valko M, Izakovic M, Mazur M, Rhodes CJ, Talser J: Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004, 266: 37-56. 10.1023/B:MCBI.0000049134.69131.89.PubMedCrossRef
65.
Zurück zum Zitat Pathak SK, Sharma RA, Steward WP, Mellon JK, Griffiths TR, Gescher AJ: Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. Eur J Cancer. 2005, 41: 61-70. 10.1016/j.ejca.2004.09.028.PubMedCrossRef Pathak SK, Sharma RA, Steward WP, Mellon JK, Griffiths TR, Gescher AJ: Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. Eur J Cancer. 2005, 41: 61-70. 10.1016/j.ejca.2004.09.028.PubMedCrossRef
66.
Zurück zum Zitat Kohen R, Nyska A: Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002, 30: 620-650. 10.1080/01926230290166724.PubMedCrossRef Kohen R, Nyska A: Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002, 30: 620-650. 10.1080/01926230290166724.PubMedCrossRef
67.
Zurück zum Zitat Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, et al: Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning. Free Radic Biol Med. 2005, 38: 698-710. 10.1016/j.freeradbiomed.2004.09.017.PubMedCrossRef Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, et al: Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning. Free Radic Biol Med. 2005, 38: 698-710. 10.1016/j.freeradbiomed.2004.09.017.PubMedCrossRef
68.
Zurück zum Zitat Milne GL, Musiek ES, Morrow JD: F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005, 10: S10-S23. 10.1080/13547500500216546.PubMedCrossRef Milne GL, Musiek ES, Morrow JD: F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005, 10: S10-S23. 10.1080/13547500500216546.PubMedCrossRef
69.
Zurück zum Zitat Mukai FH, Goldstein BD: Mutagenicity of malondialdehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science. 1976, 191: 868-869. 10.1126/science.766187.PubMedCrossRef Mukai FH, Goldstein BD: Mutagenicity of malondialdehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science. 1976, 191: 868-869. 10.1126/science.766187.PubMedCrossRef
70.
Zurück zum Zitat Basu AK, Marnett LJ: Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis. 1983, 4: 331-333. 10.1093/carcin/4.3.331.PubMedCrossRef Basu AK, Marnett LJ: Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis. 1983, 4: 331-333. 10.1093/carcin/4.3.331.PubMedCrossRef
71.
Zurück zum Zitat Boyd NF, McGuire V: Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett. 1990, 50: 31-37. 10.1016/0304-3835(90)90175-W.PubMedCrossRef Boyd NF, McGuire V: Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett. 1990, 50: 31-37. 10.1016/0304-3835(90)90175-W.PubMedCrossRef
72.
Zurück zum Zitat Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L, Jones D, Martin LJ, Lockwood G, Tritchler D: Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev. 1995, 4: 727-733.PubMed Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L, Jones D, Martin LJ, Lockwood G, Tritchler D: Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev. 1995, 4: 727-733.PubMed
73.
Zurück zum Zitat Hong CC, Tang BK, Rao V, Agarwal S, Martin L, Tritchler D, Yaffe M, Boyd NF: Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Res. 2004, 6: R338-R351. 10.1186/bcr797.PubMedPubMedCentralCrossRef Hong CC, Tang BK, Rao V, Agarwal S, Martin L, Tritchler D, Yaffe M, Boyd NF: Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Res. 2004, 6: R338-R351. 10.1186/bcr797.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Rossner P, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM: Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 639-644. 10.1158/1055-9965.EPI-05-0554.PubMedCrossRef Rossner P, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI, Santella RM: Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 639-644. 10.1158/1055-9965.EPI-05-0554.PubMedCrossRef
75.
Zurück zum Zitat Ambrosone CB: Oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000, 2: 903-917.PubMedCrossRef Ambrosone CB: Oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000, 2: 903-917.PubMedCrossRef
76.
Zurück zum Zitat Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E: Serum carotenoids and breast cancer. Am J Epidemiol. 2001, 153: 1142-1147. 10.1093/aje/153.12.1142.PubMedCrossRef Toniolo P, Van Kappel AL, Akhmedkhanov A, Ferrari P, Kato I, Shore RE, Riboli E: Serum carotenoids and breast cancer. Am J Epidemiol. 2001, 153: 1142-1147. 10.1093/aje/153.12.1142.PubMedCrossRef
77.
Zurück zum Zitat Gonenc A, Ozkan Y, Torun M, Simsek B: Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001, 26: 141-144. 10.1046/j.1365-2710.2001.00334.x.PubMedCrossRef Gonenc A, Ozkan Y, Torun M, Simsek B: Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001, 26: 141-144. 10.1046/j.1365-2710.2001.00334.x.PubMedCrossRef
78.
Zurück zum Zitat Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SA: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat. 2000, 59: 163-170. 10.1023/A:1006357330486.PubMedCrossRef Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SA: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat. 2000, 59: 163-170. 10.1023/A:1006357330486.PubMedCrossRef
79.
Zurück zum Zitat Huang YL, Sheu JY, Lin TH: Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem. 1999, 32: 131-136. 10.1016/S0009-9120(98)00096-4.PubMedCrossRef Huang YL, Sheu JY, Lin TH: Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem. 1999, 32: 131-136. 10.1016/S0009-9120(98)00096-4.PubMedCrossRef
80.
Zurück zum Zitat Wang M, Dhingra K, Hittelman WN, Liehr JG, de Andrade M, Li D: Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev. 1996, 5: 705-710.PubMed Wang M, Dhingra K, Hittelman WN, Liehr JG, de Andrade M, Li D: Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev. 1996, 5: 705-710.PubMed
81.
Zurück zum Zitat Musarrat J, Arezina-Wilson J, Wani AA: Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer. 1996, 32A: 1209-1214. 10.1016/0959-8049(96)00031-7.PubMedCrossRef Musarrat J, Arezina-Wilson J, Wani AA: Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer. 1996, 32A: 1209-1214. 10.1016/0959-8049(96)00031-7.PubMedCrossRef
82.
Zurück zum Zitat Li D, Zhang W, Zhu J, Chang P, Sahin A, Singletary E, Bondy M, Hazra T, Mitra S, Lau SS, et al: Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinog. 2001, 31: 214-223. 10.1002/mc.1056.PubMedCrossRef Li D, Zhang W, Zhu J, Chang P, Sahin A, Singletary E, Bondy M, Hazra T, Mitra S, Lau SS, et al: Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinog. 2001, 31: 214-223. 10.1002/mc.1056.PubMedCrossRef
83.
Zurück zum Zitat Yeung KS, McKeown-Eyssen GE, Li GF, Glazer E, Hay K, Child P, Gurgin V, Zhu SL, Baptista J, Aloe M, et al: Comparison of diet and biochemical characteristics of stool and urine between Chinese populations with low and high colorectal cancer rates. J Natl Cancer Inst. 1991, 83: 46-50. 10.1093/jnci/83.1.46.PubMedCrossRef Yeung KS, McKeown-Eyssen GE, Li GF, Glazer E, Hay K, Child P, Gurgin V, Zhu SL, Baptista J, Aloe M, et al: Comparison of diet and biochemical characteristics of stool and urine between Chinese populations with low and high colorectal cancer rates. J Natl Cancer Inst. 1991, 83: 46-50. 10.1093/jnci/83.1.46.PubMedCrossRef
84.
Zurück zum Zitat Tomey KM, Sowers MR, Li X, McConnell DS, Crawford S, Gold EB, Lasley B, Randolph JF: Dietary fat subgroups, zinc, and vegetable components are related to urine F2a-Isoprostane concentration, a measure of oxidative stress, in midlife women. J Nutr. 2007, 137: 2419- Tomey KM, Sowers MR, Li X, McConnell DS, Crawford S, Gold EB, Lasley B, Randolph JF: Dietary fat subgroups, zinc, and vegetable components are related to urine F2a-Isoprostane concentration, a measure of oxidative stress, in midlife women. J Nutr. 2007, 137: 2419-
85.
Zurück zum Zitat Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol. 2001, 2: 133-140. 10.1016/S1470-2045(00)00254-0.PubMedCrossRef Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol. 2001, 2: 133-140. 10.1016/S1470-2045(00)00254-0.PubMedCrossRef
86.
Zurück zum Zitat Keaney JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ, Framingham Study: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003, 23: 434-439. 10.1161/01.ATV.0000058402.34138.11.PubMedCrossRef Keaney JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ, Framingham Study: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003, 23: 434-439. 10.1161/01.ATV.0000058402.34138.11.PubMedCrossRef
87.
Zurück zum Zitat Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L: Factors associated with oxidative stress in human populations. Am J Epidemiol. 2002, 156: 274-285. 10.1093/aje/kwf029.PubMedCrossRef Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L: Factors associated with oxidative stress in human populations. Am J Epidemiol. 2002, 156: 274-285. 10.1093/aje/kwf029.PubMedCrossRef
88.
Zurück zum Zitat Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, et al: Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006, 295: 629-642. 10.1001/jama.295.6.629.PubMedCrossRef Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, et al: Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006, 295: 629-642. 10.1001/jama.295.6.629.PubMedCrossRef
89.
Zurück zum Zitat Djuric Z, Heilbrun LK, Reading BA, Boomer A, Valeriote FA, Martino S: Effects of a low-fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. J Natl Cancer Inst. 1991, 83: 766-769. 10.1093/jnci/83.11.766.PubMedCrossRef Djuric Z, Heilbrun LK, Reading BA, Boomer A, Valeriote FA, Martino S: Effects of a low-fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. J Natl Cancer Inst. 1991, 83: 766-769. 10.1093/jnci/83.11.766.PubMedCrossRef
90.
Zurück zum Zitat Karolkiewicz J, Szczesniak L, Deskur-Smielecka E, Nowak A, Stemplewski R, Szeklicki R: Oxidative stress and antioxidant defense system in healthy, elderly men: relationship to physical activity. Aging Male. 2003, 6: 100-105. 10.1080/713604768.PubMedCrossRef Karolkiewicz J, Szczesniak L, Deskur-Smielecka E, Nowak A, Stemplewski R, Szeklicki R: Oxidative stress and antioxidant defense system in healthy, elderly men: relationship to physical activity. Aging Male. 2003, 6: 100-105. 10.1080/713604768.PubMedCrossRef
91.
Zurück zum Zitat Covas MI, Elosua R, Fito M, Alcantara M, Coca L, Marrugat J: Relationship between physical activity and oxidative stress biomarkers in women. Med Sci Sports Exerc. 2002, 34: 814-819. 10.1097/00005768-200205000-00014.PubMedCrossRef Covas MI, Elosua R, Fito M, Alcantara M, Coca L, Marrugat J: Relationship between physical activity and oxidative stress biomarkers in women. Med Sci Sports Exerc. 2002, 34: 814-819. 10.1097/00005768-200205000-00014.PubMedCrossRef
92.
Zurück zum Zitat Friedenreich CM: Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev. 2001, 10: 287-301.PubMed Friedenreich CM: Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev. 2001, 10: 287-301.PubMed
93.
Zurück zum Zitat Chen Z, Wu AH, Gauderman WJ, Bernstein L, Ma H, Pike MC, Ursin G: Does mammographic density reflect ethnic differences in breast cancer incidence rates?. Am J Epidemiol. 2004, 159: 140-147. 10.1093/aje/kwh028.PubMedCrossRef Chen Z, Wu AH, Gauderman WJ, Bernstein L, Ma H, Pike MC, Ursin G: Does mammographic density reflect ethnic differences in breast cancer incidence rates?. Am J Epidemiol. 2004, 159: 140-147. 10.1093/aje/kwh028.PubMedCrossRef
94.
Zurück zum Zitat Suijkerbuijk KP, Van Duijnhoven FJ, Van Gils CH, Van Noord PA, Peeters PH, Friedenreich CM, Monninkhof EM: Physical activity in relation to mammographic density in the Dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev. 2006, 15: 456-460. 10.1158/1055-9965.EPI-05-0569.PubMedCrossRef Suijkerbuijk KP, Van Duijnhoven FJ, Van Gils CH, Van Noord PA, Peeters PH, Friedenreich CM, Monninkhof EM: Physical activity in relation to mammographic density in the Dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev. 2006, 15: 456-460. 10.1158/1055-9965.EPI-05-0569.PubMedCrossRef
95.
Zurück zum Zitat Reeves KW, Gierach GL, Modugno F: Recreational physical activity and mammographic breast density characteristics. Cancer Epidemiol Biomarkers Prev. 2007, 16: 934-942. 10.1158/1055-9965.EPI-06-0732.PubMedCrossRef Reeves KW, Gierach GL, Modugno F: Recreational physical activity and mammographic breast density characteristics. Cancer Epidemiol Biomarkers Prev. 2007, 16: 934-942. 10.1158/1055-9965.EPI-06-0732.PubMedCrossRef
96.
Zurück zum Zitat Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosello AM, Armstrong D: Correlates of oxidative stress in the general population. Am J Epidemiol. 2001, 154: 348-356. 10.1093/aje/154.4.348.PubMedCrossRef Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosello AM, Armstrong D: Correlates of oxidative stress in the general population. Am J Epidemiol. 2001, 154: 348-356. 10.1093/aje/154.4.348.PubMedCrossRef
97.
Zurück zum Zitat Wakatsuki A, Ikenoue N, Sagara Y: Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas. 1998, 28: 229-234. 10.1016/S0378-5122(97)00072-8.PubMedCrossRef Wakatsuki A, Ikenoue N, Sagara Y: Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas. 1998, 28: 229-234. 10.1016/S0378-5122(97)00072-8.PubMedCrossRef
98.
Zurück zum Zitat Thangaraju M, Vijayalakshmi T, Phil M, Sachdanandam P: Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer. 1994, 74: 78-82. 10.1002/1097-0142(19940701)74:1<78::AID-CNCR2820740114>3.0.CO;2-L.PubMedCrossRef Thangaraju M, Vijayalakshmi T, Phil M, Sachdanandam P: Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer. 1994, 74: 78-82. 10.1002/1097-0142(19940701)74:1<78::AID-CNCR2820740114>3.0.CO;2-L.PubMedCrossRef
99.
Zurück zum Zitat Gago-Dominguez M, Castelao JE, Pike MC, Sevanian A, Haile RW: Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2829-2839. 10.1158/1055-9965.EPI-05-0015.PubMedCrossRef Gago-Dominguez M, Castelao JE, Pike MC, Sevanian A, Haile RW: Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2829-2839. 10.1158/1055-9965.EPI-05-0015.PubMedCrossRef
100.
Zurück zum Zitat Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A: Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol. 2002, 22: 438-442. 10.1161/hq0302.104515.PubMedCrossRef Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A: Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol. 2002, 22: 438-442. 10.1161/hq0302.104515.PubMedCrossRef
101.
Zurück zum Zitat Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, et al: Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA. 1998, 279: 535-540. 10.1001/jama.279.7.535.PubMedCrossRef Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, et al: Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA. 1998, 279: 535-540. 10.1001/jama.279.7.535.PubMedCrossRef
102.
Zurück zum Zitat Hartman TJ, Baer DJ, Graham LB, Stone WL, Gunter EW, Parker CE, Albert PS, Dorgan JF, Clevidence BA, Campbell WS, et al: Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women. Eur J Clin Nutr. 2005, 59: 161-168. 10.1038/sj.ejcn.1602051.PubMedCrossRef Hartman TJ, Baer DJ, Graham LB, Stone WL, Gunter EW, Parker CE, Albert PS, Dorgan JF, Clevidence BA, Campbell WS, et al: Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women. Eur J Clin Nutr. 2005, 59: 161-168. 10.1038/sj.ejcn.1602051.PubMedCrossRef
103.
Zurück zum Zitat Maskarinec G, Takata Y, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Alcohol consumption and mammographic density in a multiethnic population. Int J Cancer. 2006, 118: 2579-2583. 10.1002/ijc.21705.PubMedCrossRef Maskarinec G, Takata Y, Pagano I, Lurie G, Wilkens LR, Kolonel LN: Alcohol consumption and mammographic density in a multiethnic population. Int J Cancer. 2006, 118: 2579-2583. 10.1002/ijc.21705.PubMedCrossRef
104.
Zurück zum Zitat Davies KJA: The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life. 1999, 48: 41-47. 10.1080/713803463.PubMedCrossRef Davies KJA: The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life. 1999, 48: 41-47. 10.1080/713803463.PubMedCrossRef
105.
Zurück zum Zitat Comporti M, Arezzini B, Signorini C, Sgherri C, Monaco B, Gardi C: F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?. Lab Invest. 2005, 85: 1381-1391. 10.1038/labinvest.3700332.PubMedCrossRef Comporti M, Arezzini B, Signorini C, Sgherri C, Monaco B, Gardi C: F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?. Lab Invest. 2005, 85: 1381-1391. 10.1038/labinvest.3700332.PubMedCrossRef
106.
Zurück zum Zitat Hinz B: Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007, 127: 526-537. 10.1038/sj.jid.5700613.PubMedCrossRef Hinz B: Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007, 127: 526-537. 10.1038/sj.jid.5700613.PubMedCrossRef
107.
Zurück zum Zitat Marks F, Furstenberger G, Muller-Decker K: Tumor promotion as a target of cancer prevention. Recent Results Cancer Res. 2007, 174: 37-47.PubMedCrossRef Marks F, Furstenberger G, Muller-Decker K: Tumor promotion as a target of cancer prevention. Recent Results Cancer Res. 2007, 174: 37-47.PubMedCrossRef
108.
Zurück zum Zitat Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer. 2006, 6: 392-401. 10.1038/nrc1877.PubMedCrossRef Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer. 2006, 6: 392-401. 10.1038/nrc1877.PubMedCrossRef
109.
Zurück zum Zitat Boyd NF, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL: The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer. 1998, 78: 1233-1238.PubMedPubMedCentralCrossRef Boyd NF, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL: The relationship of anthropometric measures to radiological features of the breast in premenopausal women. Br J Cancer. 1998, 78: 1233-1238.PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat Wolfe JN, Albert S, Belle S, Salane M: Familial influences on breast parenchymal patterns. Cancer. 1980, 46: 2433-2437. 10.1002/1097-0142(19801201)46:11<2433::AID-CNCR2820461123>3.0.CO;2-E.PubMedCrossRef Wolfe JN, Albert S, Belle S, Salane M: Familial influences on breast parenchymal patterns. Cancer. 1980, 46: 2433-2437. 10.1002/1097-0142(19801201)46:11<2433::AID-CNCR2820461123>3.0.CO;2-E.PubMedCrossRef
111.
Zurück zum Zitat Haars G, van Noord PAH, van Gils CH, Peeters PHM, Grobbee DE: Heritable aspects of dysplastic breast glandular tissue (DY). Breast Cancer Res Treat. 2004, 87: 149-156. 10.1023/B:BREA.0000041621.48575.9b.PubMedCrossRef Haars G, van Noord PAH, van Gils CH, Peeters PHM, Grobbee DE: Heritable aspects of dysplastic breast glandular tissue (DY). Breast Cancer Res Treat. 2004, 87: 149-156. 10.1023/B:BREA.0000041621.48575.9b.PubMedCrossRef
112.
Zurück zum Zitat Kaprio J, Alanko A, Kivisaari L: Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol. 1987, 60: 459-462.PubMedCrossRef Kaprio J, Alanko A, Kivisaari L: Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol. 1987, 60: 459-462.PubMedCrossRef
113.
Zurück zum Zitat Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA: Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst. 1997, 89: 549-556. 10.1093/jnci/89.8.549.PubMedCrossRef Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA: Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst. 1997, 89: 549-556. 10.1093/jnci/89.8.549.PubMedCrossRef
114.
Zurück zum Zitat Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, et al: Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med. 2002, 347: 886-894. 10.1056/NEJMoa013390.PubMedCrossRef Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, et al: Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med. 2002, 347: 886-894. 10.1056/NEJMoa013390.PubMedCrossRef
115.
Zurück zum Zitat Vachon CM, King RA, Atwood LD, Kuni CC, Sellers TA: Preliminary sibpair linkage analysis of percent mammographic density. J Natl Cancer Inst. 1999, 91: 1778-1779. 10.1093/jnci/91.20.1778.PubMedCrossRef Vachon CM, King RA, Atwood LD, Kuni CC, Sellers TA: Preliminary sibpair linkage analysis of percent mammographic density. J Natl Cancer Inst. 1999, 91: 1778-1779. 10.1093/jnci/91.20.1778.PubMedCrossRef
116.
Zurück zum Zitat Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA, Smalley RL, Schaid DJ, Kelemen LE, Couch FJ, Pankratz VS: Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res. 2007, 67: 8412-8418. 10.1158/0008-5472.CAN-07-1076.PubMedCrossRef Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA, Smalley RL, Schaid DJ, Kelemen LE, Couch FJ, Pankratz VS: Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res. 2007, 67: 8412-8418. 10.1158/0008-5472.CAN-07-1076.PubMedCrossRef
117.
Zurück zum Zitat Hong C-C, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF: Val158Met Polymorphism in catechol-O-methyltransferase (COMT) gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2003, 12: 838-847.PubMed Hong C-C, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF: Val158Met Polymorphism in catechol-O-methyltransferase (COMT) gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2003, 12: 838-847.PubMed
118.
Zurück zum Zitat Maskarinec G, Luire G, Williams AE, Marchand L: An investigation of mammographic density and gene variants in healthy women. Int J Cancer. 2004, 112: 683-688. 10.1002/ijc.20448.PubMedCrossRef Maskarinec G, Luire G, Williams AE, Marchand L: An investigation of mammographic density and gene variants in healthy women. Int J Cancer. 2004, 112: 683-688. 10.1002/ijc.20448.PubMedCrossRef
119.
Zurück zum Zitat Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G: Genetic determinants of mammographic density. Breast Cancer Res. 2002, 4: R5-10.1186/bcr434.PubMedPubMedCentralCrossRef Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G: Genetic determinants of mammographic density. Breast Cancer Res. 2002, 4: R5-10.1186/bcr434.PubMedPubMedCentralCrossRef
120.
Zurück zum Zitat Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003, 77: 27-36. 10.1023/A:1021112121782.PubMedCrossRef Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003, 77: 27-36. 10.1023/A:1021112121782.PubMedCrossRef
121.
Zurück zum Zitat van Duijnhoven FJ, Bezemer ID, Peeters PH, Roest M, Uitterlinden AG, Grobbee DE, van Gils CH: Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2655-2660. 10.1158/1055-9965.EPI-05-0398.PubMedCrossRef van Duijnhoven FJ, Bezemer ID, Peeters PH, Roest M, Uitterlinden AG, Grobbee DE, van Gils CH: Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2655-2660. 10.1158/1055-9965.EPI-05-0398.PubMedCrossRef
122.
Zurück zum Zitat Lillie EO, Bernstein L, Ingles SA, Gauderman WJ, Rivas GE, Gagalang V, Krontiris T, Ursin G: Polymorphism in the androgen receptor and mammographic density in women taking and not taking estrogen and progestin therapy. Cancer Res. 2004, 64: 1237-1241. 10.1158/0008-5472.CAN-03-2887.PubMedCrossRef Lillie EO, Bernstein L, Ingles SA, Gauderman WJ, Rivas GE, Gagalang V, Krontiris T, Ursin G: Polymorphism in the androgen receptor and mammographic density in women taking and not taking estrogen and progestin therapy. Cancer Res. 2004, 64: 1237-1241. 10.1158/0008-5472.CAN-03-2887.PubMedCrossRef
123.
Zurück zum Zitat Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA: A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2004, 13: 573-582.PubMed Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA: A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2004, 13: 573-582.PubMed
124.
Zurück zum Zitat Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA: Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res. 2007, 9: R18-10.1186/bcr1655.PubMedPubMedCentralCrossRef Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I, Freedman ML, Hankinson SE, Hunter DJ, Colditz GA: Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res. 2007, 9: R18-10.1186/bcr1655.PubMedPubMedCentralCrossRef
125.
Zurück zum Zitat Mulhall C, Hegele R, Cao H, Tritchler D, Yaffe M, Boyd NF: Mammographic density and the pituitary growth hormone and growth hormone releasing hormone receptor genes. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2648-2654. 10.1158/1055-9965.EPI-04-0374.PubMedCrossRef Mulhall C, Hegele R, Cao H, Tritchler D, Yaffe M, Boyd NF: Mammographic density and the pituitary growth hormone and growth hormone releasing hormone receptor genes. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2648-2654. 10.1158/1055-9965.EPI-04-0374.PubMedCrossRef
126.
Zurück zum Zitat Dunning AM, Healey CS, Pharoah PDP, Teare MD, Ponder BAJ, Easton DF: A systematic review of genetic polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999, 8: 843-854.PubMed Dunning AM, Healey CS, Pharoah PDP, Teare MD, Ponder BAJ, Easton DF: A systematic review of genetic polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999, 8: 843-854.PubMed
127.
Zurück zum Zitat Lamberts SWJ, van den Beld AW, van der Lely A-J: The endocrinology of aging. Science. 1997, 278: 419-424. 10.1126/science.278.5337.419.PubMedCrossRef Lamberts SWJ, van den Beld AW, van der Lely A-J: The endocrinology of aging. Science. 1997, 278: 419-424. 10.1126/science.278.5337.419.PubMedCrossRef
128.
Zurück zum Zitat van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, Uitterlinden AG, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH: Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol Biomarkers Prev. 2006, 15: 462-467. 10.1158/1055-9965.EPI-05-0754.PubMedCrossRef van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, Uitterlinden AG, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH: Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol Biomarkers Prev. 2006, 15: 462-467. 10.1158/1055-9965.EPI-05-0754.PubMedCrossRef
129.
Zurück zum Zitat Bissell MJ, Rizki A, Mian IS: Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol. 2003, 15: 753-762. 10.1016/j.ceb.2003.10.016.PubMedPubMedCentralCrossRef Bissell MJ, Rizki A, Mian IS: Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol. 2003, 15: 753-762. 10.1016/j.ceb.2003.10.016.PubMedPubMedCentralCrossRef
130.
Zurück zum Zitat Rodriguez-Antona C, Ingelman-Sundberg M: Cytochrome P 450 pharmacogenetics and cancer. Oncogene. 2006, 25: 1679-1691. 10.1038/sj.onc.1209377.PubMedCrossRef Rodriguez-Antona C, Ingelman-Sundberg M: Cytochrome P 450 pharmacogenetics and cancer. Oncogene. 2006, 25: 1679-1691. 10.1038/sj.onc.1209377.PubMedCrossRef
131.
Zurück zum Zitat Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002, 108: 171-182. 10.1016/S0092-8674(02)00615-3.PubMedCrossRef Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002, 108: 171-182. 10.1016/S0092-8674(02)00615-3.PubMedCrossRef
132.
Zurück zum Zitat Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL: Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. Biomarkers in Cancer Chemoprevention. Edited by: Miller AB, Bartsch H, Boffetta P, Dragsted L, Vainio H. 2001, Lyon, France: International Agency for Research on Cancer, 163-169. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL: Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. Biomarkers in Cancer Chemoprevention. Edited by: Miller AB, Bartsch H, Boffetta P, Dragsted L, Vainio H. 2001, Lyon, France: International Agency for Research on Cancer, 163-169.
133.
Zurück zum Zitat Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol. 2001, 11: 97-104. 10.1006/scbi.2000.0361.PubMedCrossRef Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol. 2001, 11: 97-104. 10.1006/scbi.2000.0361.PubMedCrossRef
134.
Zurück zum Zitat Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer Res. 1990, 50: 7415-7421.PubMed Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer Res. 1990, 50: 7415-7421.PubMed
Metadaten
Titel
Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence
verfasst von
Lisa J Martin
Norman F Boyd
Publikationsdatum
01.02.2008
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe Sonderheft 1/2008
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1831

Weitere Artikel der Sonderheft 1/2008

Breast Cancer Research 1/2008 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.